High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
出版年份 2020 全文链接
标题
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201921964
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-05-28
DOI
10.1073/pnas.1921964117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutation position is an important determinant for predicting cancer neoantigens
- (2020) Aude-Hélène Capietto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel TCR-based biologics: mobilising T cells to warm ‘cold’ tumours
- (2019) Kate L. Lowe et al. CANCER TREATMENT REVIEWS
- Determinants for Neoantigen Identification
- (2019) Andrea Garcia-Garijo et al. Frontiers in Immunology
- Neoantigen quality, not quantity
- (2019) Nicholas McGranahan et al. Science Translational Medicine
- Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy
- (2019) Yong-Chen Lu et al. Cancer Immunology Research
- Structure Based Prediction of Neoantigen Immunogenicity
- (2019) Timothy P. Riley et al. Frontiers in Immunology
- Developing neoantigen-targeted T cell–based treatments for solid tumors
- (2019) Tori N. Yamamoto et al. NATURE MEDICINE
- Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide
- (2018) Kok Fei Chan et al. Nature Communications
- Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices
- (2017) Moreno Di Marco et al. JOURNAL OF IMMUNOLOGY
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope
- (2017) InYoung Song et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- T-Cell Transfer Therapy Targeting Mutant KRAS
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- STCRDab: the structural T-cell receptor database
- (2017) Jinwoo Leem et al. NUCLEIC ACIDS RESEARCH
- ATLAS: A database linking binding affinities with structures for wild-type and mutant TCR-pMHC complexes
- (2017) Tyler Borrman et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Structural and regulatory diversity shape HLA-C protein expression levels
- (2017) Gurman Kaur et al. Nature Communications
- Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope
- (2017) InYoung Song et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8 + TCR Repertoires to Immunodominant Viral Antigens
- (2017) Guobing Chen et al. Cell Reports
- Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
- (2017) Danilo Presotto et al. Frontiers in Immunology
- Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C
- (2017) Malcolm J. W. Sim et al. Frontiers in Immunology
- RAS isoforms and mutations in cancer at a glance
- (2016) G. Aaron Hobbs et al. JOURNAL OF CELL SCIENCE
- Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- (2016) Stephanie L. Goff et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide–MHC complexes
- (2016) Lance M. Hellman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Drugging the Undruggable Ras — Immunotherapy to the Rescue?
- (2016) Carl H. June NEW ENGLAND JOURNAL OF MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
- (2015) Jamie Rossjohn et al. Annual Review of Immunology
- Landscape of Tumor Antigens in T Cell Immunotherapy
- (2015) S. Ilyas et al. JOURNAL OF IMMUNOLOGY
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- Dragging Ras Back in the Ring
- (2014) Andrew G. Stephen et al. CANCER CELL
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Contribution of TCR Signaling Strength to CD8+T Cell Peripheral Tolerance Mechanisms
- (2014) Trevor R. F. Smith et al. JOURNAL OF IMMUNOLOGY
- The Immunodominant Influenza A Virus M158-66 Cytotoxic T Lymphocyte Epitope Exhibits Degenerate Class I Major Histocompatibility Complex Restriction in Humans
- (2014) J. A. L. Choo et al. JOURNAL OF VIROLOGY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Virus-Specific CD4+ Memory-Phenotype T Cells Are Abundant in Unexposed Adults
- (2013) Laura F. Su et al. IMMUNITY
- SHP-1 phosphatase activity counteracts increased T cell receptor affinity
- (2013) Michael Hebeisen et al. JOURNAL OF CLINICAL INVESTIGATION
- T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy
- (2013) S. Zhong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
- (2013) Jennifer D. Stone et al. Frontiers in Immunology
- Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
- (2012) Milos Aleksic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Improving T cell responses to modified peptides in tumor vaccines
- (2012) Jonathan D. Buhrman et al. IMMUNOLOGIC RESEARCH
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- αβ T Cell Receptors that Do Not Undergo Major Histocompatibility Complex-Specific Thymic Selection Possess Antibody-like Recognition Specificities
- (2011) Anastasia N. Tikhonova et al. IMMUNITY
- Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
- (2010) D. A. Schmid et al. JOURNAL OF IMMUNOLOGY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- The Goldilocks Model for TCR—Too Much Attraction Might Not Be Best for Vaccine Design
- (2010) Jill E. Slansky et al. PLOS BIOLOGY
- Attenuated T Cell Responses to a High-Potency Ligand In Vivo
- (2010) Emily Corse et al. PLOS BIOLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- The molecular basis of TCR germline bias for MHC is surprisingly simple
- (2009) K Christopher Garcia et al. NATURE IMMUNOLOGY
- Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition
- (2008) S Yang et al. GENE THERAPY
- Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
- (2008) D. C. Palmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started